PropertyValue
?:definition
  • Molecular assay reagents intended to identify genetic variants in the majority of genes known to be associated with metabolic disorders, a collection of diseases characterized by deficiencies in the synthesis or degradation of various chemicals used by the body (e.g., proteins, carbohydrates, lipids). Genetic variants at multiple loci have been associated with metabolic disorders. These reagents are intended to detect various types of genetic changes (e.g., deletions, duplications, insertions, single nucleotide polymorphisms) in the majority of metabolic disorder-associated loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C0078844_Pharmacokynetic_C2698585>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C0078844_Pharmacokynetic_C2698585>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all